Hepatic safety also confirmed over six months of treatment with mealtime liver targeted insulin Company focused on Phase 3 initiation in 2020 CLEVELAND, June 10, 2019 (GLOBE NEWSWIRE) -- Diasome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results